作为心血管风险因素的MAFLD:与对照组进行了扩展后期研究
Małgorzata Szymala-Pędzik1, Marcin Piersiak2, Maciej Pachana3
1Department of Geriatrics, Wroclaw Medical University, 50556 Wroclaw, Poland.
Journal of clinical medicine
|June 26, 2025
概括
与代谢相关的脂肪肝疾病 (MAFLD) 与老年人心血管风险增加有关. 这项研究发现,MAFLD患者的体重,BMI和糖尿病和高甘油三血症的频率更高,这表明MAFLD是心脏代谢风险的关键指标.
科学领域:
- 老年医学 老年医学
- 心脏病学 心脏病学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 代谢相关脂肪肝 (MAFLD) 是全球最常见的肝脏疾病,影响25%-30%的人口.
- MAFLD与代谢功能障碍,超重,肥胖和2型糖尿病密切相关.
- 2020年将脂肪肝疾病重新定义为MAFLD,强调其心脏代谢影响.
研究的目的:
- 在老年人群中评估MAFLD和心血管风险因素之间的关联.
- 为了比较患有和没有MAFLD的患者的心血管风险概况.
- 评估新陈代谢和心声学参数对老年人MAFLD患病率的影响.
主要方法:
- 对237名MAFLD患者和148名来自大学医院老年病科的对照者的回顾性研究.
- 组之间的并发症,实验室值,BMI和左心室缩的比较.
- 统计分析以确定所选变量与MAFLD风险之间的关联.
主要成果:
- 与对照组相比,MAFLD患者的体重和BMI显著增加.
- 在MAFLD组中观察到糖尿病和高甘油三血症的更高患病率,以及较低的HDL和维生素D3水平.
- 在MAFLD患者中,左心室缩的心声学指标的升高显著更高.
结论:
- 在老年患者中,MAFLD与心血管风险因素密切相关.
- 这项研究支持MAFLD作为老年护理中的独立心脏代谢风险指标的作用.
- 使用对照组提高了MAFLD风险评估的准确性.
相关概念视频
01:30Coronary Artery Disease I: Introduction
69
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
69
01:26Coronary Artery Disease IV: Preventive Measures
39
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
39
01:26Atherosclerosis III: Management
42
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
42
01:23Assessment of the Cardiovascular System I: Subjective Data
476
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
476
01:26Coronary Artery Disease II: Pathophysiology
42
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
42
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
353
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
353